In 1950, Dr Tavia Gordon noticed that while the overall mortality rates for men in the USA and Japan were very similar, the incidence of heart disease was significantly lower in Japan. This observation resulted in three longitudinal studies – one of which became known as the Honolulu Heart Study.
Dr Travis Gordon. Source: JSTOR
The original purpose of the study was to determine whether there was a difference in heart disease incidence between Japanese people living in Japan and individuals of Japanese ancestry living in Hawaii.
The subjects recruited for the study were “non-institutionalized men of Japanese ancestry, born 1900-1919, resident on the island of Oahu.” In all, 12,417 men were identified as meeting the criteria. Of those contacted, 1,269 questionnaires were ‘return to sender’, 2,962 men declined to participate in the study, and 180 died before the study commenced. That left 8,006 participants who would be studied and followed for the rest of their lives.
From October 1965 onwards, the participants were interviewed and given physical examinations every few years. The interview processed asked for:
- Family and personal history of illness
- Sociological history
- Smoking status
- Physical activity level
The physical examination was very thorough, looking at:
- ECG (Electrocardiography – electrical activity of the heart)
- Urine analysis
- Measurements of weight, height, skinfold thickness, etc.
- Blood pressure and serum cholesterol
As a result, the study built up a HUGE amount of epidemiological information regarding these 8,006 individuals.
So, what does this have to do with Parkinson’s disease????
Given the enormous number of individuals involved in the study and the length of time that they were followed, it was inevitable that a certain percentage of them would develop Parkinson’s disease as the study progressed. As a result, the Honolulu Heart Study represents one of the largest epidemiological study of Parkinson’s to date. In 1994, a group of research involved in the study, published some very interesting findings relating to Parkinson’s disease. That published article was:
Title: Epidemiologic observations on Parkinson’s disease: incidence and mortality in a prospective study of middle-aged men.
Authors: Morens DM, Davis JW, Grandinetti A, Ross GW, Popper JS, White LR.
Journal: Neurology, 1996 Apr;46(4):1044-50.
In total, 92 of the 8006 individuals enrolled in the study developed Parkinson’s disease. The incidence of Parkinson’s cases was registered between 1965 and November 30th 1994. The majority of the cases were diagnosed between 55 and 79 years of age (n=80). Diagnosis after the age of 80 was very rare. It is interesting to note that when the researchers divided the group into those ‘born before 1910’ and those ‘born after 1910’, the older group (born before 1910) had a lower risk of Parkinson’s disease.
In another study, the same group of investigators noted
Title: Prospective study of cigarette smoking and the risk of developing idiopathic Parkinson’s disease.
Authors: Grandinetti A, Morens DM, Reed D, MacEachern D.
Journal: American Journal of Epidemiology 1994 Jun 15;139(12):1129-38.
In this study the authors found that men who had smoked cigarettes at any time prior to their enrollment in the study in 1965, had a reduced risk of developing idiopathic Parkinson’s disease (relative risk = 0.39). That is to say, smoking reduced the chance of developing Parkinson’s disease. And a few years later the authors published a follow up paper which rejected the possibility that smoking was killing people before they could develop Parkinson’s disease (selective mortality representing a false positive). That follow up report can be found here.
EDITOR’S NOTE: THIS DOES NOT MEAN THAT EVERYONE SHOULD RUSH OUT AND START SMOKING. THERE DOES, HOWEVER, APPEAR TO BE SOME INGREDIENT IN CIGARETTES THAT REDUCES THE INCIDENCE OF PARKINSON’S DISEASE. A LOT OF RESEARCH IS CURRENTLY TRYING TO IDENTIFY THAT INGREDIENT.
This finding was made alongside other interesting correlations (Note: coffee and alcohol reduce the risk of Parkinson’s disease):
From Grandinetti et al (1994).
It should be noted that many of these associations (smoking in particular) had been reported before, but the Honolulu Heart Study was the first epidemiological study providing definitive proof. And it should be noted that subsequent epidemiological studies have found similar results.
INTERESTING FACTS ABOUT THE JAPANESE:
- The Japanese as a population have a lower incidence of Parkinson’s disease (much like most of the Asian nations) than their western equivalents, despite living longer.
- Japan is the only country in the world where females have a higher incidence of Parkinson’s disease than men (and we have no idea why!). Look here for more on this.
16 thoughts on “The Honolulu Heart Study”
I have 20 First cousins on my Paternal side. Six developed Parkinson’s, and I am one of them. My symptoms did not develop until I quit smoking, and I smoked for 49 years. The last 10 years of so required nicotine about every 2 hours. Sigh, I won’t start again ( yet ), but temped to try it at some time in the future. I’m 72, and female.
Apparently nicotine protects dopaminergic neurons by blocking MAO-B, the enzyme that metabolizes dopamine. Effect confirmed by mouse study in which nicotine protects against MPP+. However, this probably just symptomatic. No effect on a-syn, so probably no effect on development of dementia.